$Novo Nordisk AS(NVO.US) Just now (early morning Eastern Time), Novo Nordisk has pre-released its 2025 annual report and 2026 guidance on its official website. Since the guidance mentioned that the 2026 profit growth expectation is -5% to -13%, this huge negative news caused the stock in Copenhagen to experience severe fluctuations at the opening and even triggered a trading halt (Volatility Halt).
US stock linkage: The US stock NVO is an ADR (American Depositary Receipt). Due to the severe fluctuations or halts in European stocks, the pre-market liquidity of US stocks will dry up instantly, causing the software to display "suspension" or a static price.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
